Indication
Diabetic Vitreous Hemorrhage
1 clinical trial
2 products
Clinical trial
A Randomized, Double-masked, Sham-controlled Study to Evaluate the Efficacy of Peri-operative Farcimab in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic RetinopathyStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Product
FaricimabProduct
Sham Treatment